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Abstract
Background: Dialectical behavioral therapy (DBT) skills have become increasingly used to treat several psychiatric
conditions, including major depressive disorder (MDD). The aim of the study was to investigate the efficacy of an
intervention that combines emotion regulation and mindfulness skills of DBT to prevent depression relapse/recurrence.
Methods: A total of 75 individuals (79% females; mean age, 52 years) with a diagnosis of MDD in complete or partial
remission were recruited. Participants were randomly allocated either to an intervention combining emotion regulation
and mindfulness skills (ER +M group, n= 37) or to a psychoeducative program (n = 38). After the 10-week treatment
period, participants were followed for 1 year. Analyses were run in per-protocol (PP) and intention-to-treat (ITT) samples.
The primary outcome measure was time to depression relapse/recurrence.
Results: ER +M training was not more effective than the control intervention in preventing depression relapse. However,
PP and ITT analyses showed that participants trained in ER +M presented a significant reduction in depressive symptoms
and overall psychopathology. Based on the PP and ITT analyses, neither of the interventions were related with an increase
in dispositional mindfulness.
Conclusions: More studies are needed to confirm the efficacy of ER +M to decrease depressive symptoms and overall
psychopathology.
Trial registration: NCT02747134. Registered on 20 April 2016.
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Background
Major Depressive Disorder (MDD) is one of the most
prevalent and disabling mental disorders, and it is fre-
quently associated with a high risk of suicide [1]. The
World Health Organization estimates that, by the year
2030, depression will be the leading cause of disease bur-
den globally [2]. This disorder has a highly recurrent
nature and a poor long-term prognosis because the
probability of another depressive episode increases with
each relapse/recurrence. Available studies have reported
relapse rates ranging from 50 to 90%, and these data sug-
gest that a patient diagnosed with MDD will experience
an average of four episodes during his/her lifetime [3].
These high relapse rates require effective treatments, not
only to manage depressive symptoms in the acute phase,
but especially to develop effective interventions to prevent
relapse and recurrence.
Dialectical Behavioral Therapy (DBT) is a multi-
component treatment initially developed for patients
with borderline personality disorder [4]. Because DBT is
based on a skills deficit model, the treatment focuses on
skills training. In standard DBT, skills are organized into
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four modules: mindfulness, interpersonal effectiveness,
emotion regulation, and distress tolerance [5]. In recent
years, DBT—particularly, DBT skill training—has been
used to treat diverse populations affected by emotion
dysregulation [6]. In subjects with an MDD diagnosis,
some studies have compared the effects of DBT skills
training to antidepressant medications (AM). The first
study to perform this comparison [7] found no signifi-
cant differences between the interventions in terms of
improvement in depression symptoms or post-treatment
remission rates (28 weeks). However, that study did find
that remission rates were more favorable in the DBT
group (75% vs. 31%) after 6 months of follow up [7].
These findings were subsequently confirmed in another
study [8] in which a significantly higher number of pa-
tients receiving DBT + AM achieved remission (both at
post-treatment and follow-up) compared to AM alone.
Findings from a pilot study conducted by Harley et al.
showed that skills training was more efficacious than
treatment as usual (TAU) to decrease depression in indi-
viduals with treatment-resistant MDD [9].
One of the major advantages of DBT skill training is that
clinicians can combine these skills in different ways to tar-
get specific clinical symptoms. This allows implementation
of DBT skill training in settings where delivering the
complete DBT treatment package would not be feasible.
Furthermore, recent research suggests that some skills
could be more closely related to positive clinical outcomes
than others [10, 11]. Among the various DBT skills, we
hypothesize that emotion regulation (ER) and mindfulness
(M) skills may be specifically beneficial for patients with
MDD diagnosis. ER refers to the set of skills used for un-
derstanding and learning to regulate emotions by 1)
attending to emotional vulnerability to cues, 2) managing
attention and appraisal of the cues, 3) changing physio-
logical, cognitive, and experiential responses and action
urges, and 4) dealing with the consequences of the emo-
tional response [12]. The successful application of ER skills
has been associated with a significant decrease in the sever-
ity of depressive symptoms [13, 14]. For instance, Berking
and colleagues [15] assessed participants with MDD cri-
teria enrolled in a treatment program consisting of CBT +
ER training, finding that these patients experienced a
greater reduction in depression and negative affect as well
as a larger increase of well-being, compared to those re-
ceiving only CBT. In DBT, ER skills training is oriented to
encouraging behavioral activation (BA) by training patients
in “opposite action” (OA) to depressive symptoms. OA
training aims to target avoidance by changing expressions
(facial and postural) and behavior in a way that is opposite
to feelings of sadness. DBT also includes skills training to
help subjects obtain positive emotions in both the short
and long-term by increasing daily pleasant events and by
fostering values-related activities [6].
Like DBT, there are other interventions that contain
mindfulness training, including Mindfulness-Based Cog-
nitive Therapy (MBCT) [16], which is also focused on
increasing acceptance and ER. Research on MBCT sug-
gests that increasing mindfulness skills could be crucial
to prevent MDD relapse by helping patients to identify
and disengage from cognitive non-adaptive patterns,
thus avoiding the re-establishment of a depressive
episode [17–20].
In this context, we designed the present randomized
controlled study to investigate the efficacy of an inter-
vention that combines ER with mindfulness (ER +M)
skills to reduce rates of depressive relapse/recurrence.
Participants with a previous diagnosis of MDD in partial
or total remission were considered eligible to participate.
A second aim was to assess the effects of the interven-
tion on depressive symptoms, general psychiatric symp-
toms, and mindfulness capacities.
Methods
Participants and recruitment
A total of 110 patients were assessed for eligibility and 75
were included in the study. Participants were recruited
from outpatient facilities at the Psychiatric Service of the
Hospital de la Santa Creu I Sant Pau and from the Adult
Mental Health Center (Barcelona, Spain). Based on effect
sizes reported in similar, previous research studies [17, 18]
and considering an expected relapse/recurrence rate of 35
and 70%, respectively, in the treatment (ER +M) and con-
trol groups (psychoeducation), a minimum sample of 60
participants (30 per group) was required to ensure power
of .80 at a significance level of α = .05 [19].
Inclusion criteria were: 1) age 18 to 75 years; 2) previ-
ous diagnosis of MDD in complete or partial remission
(according to the major depressive section of the Struc-
tured Clinical Interview for DSM-IV Axis I Disorders;
SCID-I) at study inclusion and scores < 17 on the
Hamilton Depression Rating Scale (HDRS); 3) having ex-
perienced the last major depressive episode between 18
and 2 months prior to study initiation; 4) at least two
previous depressive episodes; 5) pharmacological treat-
ments were permitted provided that the medication(s)
remained unchanged for the 2 months before inclusion
in the study. Exclusion criteria were: 1) current MDD or
any other affective disorder (DSM-IV-TR criteria); 2) al-
cohol or drug dependence, schizophrenia or psychotic
disorders (DSM-IV-TR criteria); 3) personality disorders
(DSM-IV-TR criteria); severe physical conditions such as
organic brain syndrome, neurological disease; mental
retardation or cognitive impairments; 4) current psycho-
logical treatment; 5) changes in pharmacological treat-
ment during the study.
An independent statistician randomized the partici-
pants who met all inclusion criteria using a computer-
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generated sequence (blocks of four participants without
stratification). The study coordinators informed the pa-
tients about their treatment assignment, but the inter-
viewers were blinded to the patient’s condition throughout
the study. Participants were instructed not to disclose in-
formation about their treatment group to the interviewer.
Participants were informed of the study procedures
and required to sign the informed consent form prior to
the assessments. Participants received no payments of
any kind for taking part in the study. The trial protocol
was approved by the ethics committee of the Hospital
de la Santa Creu I Sant Pau and was retrospectively
registered on clinicaltrials.gov (NCT02747134).
Study design and procedures
This was a randomized, single blind, two–arm (experi-
mental and control) clinical trial. The study consisted of
two phases: phase 1: treatment (10 weeks) and phase II:
1-year (52 week) follow-up period. Primary outcome
measures were assessed at three time points during the
treatment phase [i.e., pre-intervention, intervention mid-
point (5 weeks) and post-intervention] and bi-monthly
during the follow-up period. Assessments of secondary
outcomes were conducted at only two time points: pre-
and-post intervention.
The primary outcome measure was time to relapse/re-
currence of major depression, which was defined as
meeting SCID-I criteria for at least 2 weeks. In the
follow-up assessments, participants were asked to esti-
mate, as precisely as possible, the data of onset of the
depressive episode. If the participant could remember
the month but not the day of onset, the relapse/recur-
rence was coded as occurring in the middle of the
month (second week). In patients who reported onset at
the “beginning of the month”, the relapse/recurrence
was encoded as occurring in the first week of the month
while “end of the month” was encoded as the fourth
week of the month. If a participant presented relapse cri-
teria at the time of the follow up interview, an additional
interview was scheduled for the next week to determine
if symptoms were present for at least 15 days.
Treatments
Both interventions were applied in a group format of 8 to
12 participants each. The ER +M treatments consisted of
10 sessions (once weekly, 120 min each). The psychoedu-
cation treatments consisted of five sessions, delivered
every 2 weeks (90 min). The treatments in both groups
were scheduled this way to ensure that the time frame of
both interventions was the same (i.e., 10 weeks).
Emotion regulation and mindfulness skills (ER + M)
This intervention was performed in accordance with the
principles and structure of DBT skills training. Participants
were given step-by-step instructions, rehearsal exercises,
and homework assignments to practice the skills learned in
the sessions. The first session provided an overview of the
training goals and an explanation of the differences
between the three states of mind (i.e., emotional mind,
rational mind and wise mind). Thereafter, “what” (i.e.,
describe, observe, participate) and “how” (i.e., without judg-
ing, being effective, and one-mindfully) mindfulness skills
were presented and practiced during the session. Sessions
3 to 10 began with 10–15 min of mindfulness practice
followed by homework review. The focus of these sessions
was on behavioral activation skills, including “opposite
action”, “accumulating positive emotions” (i.e., increasing
daily positive experiences in the short and long term) and
“building mastery” (i.e., engaging in activities that foster a
sense of self-efficacy and competency) [4]. As with mind-
fulness skills, participants were instructed to practice the
ER exercises during the week and each therapy session
began with the review of homework assignments. The con-
tent of each session was tailored to participants with
MDD. For example, mindfulness practice included exam-
ples of how to deal with negative thoughts and emotions
(e.g., sadness, guilt, anger) associated with depressive states.
Similarly, ER skills were oriented towards fostering “oppos-
ite action” to sadness and to increasing the occurrence of
positive life-events. Two DBT-certified therapists (therapist
and co-therapist) with extensive training in DBT and
mindfulness-based interventions conducted the treatment.
In order to provide feedback and supervision of the inter-
ventions, other team members followed the sessions using
a closed-circuit television. Video cameras transmitted the
signal but the sessions were not recorded.
Psychoeducation
The psycho-educative program aimed at providing general
education about MDD, increasing the patient’s knowledge
about depression and depression relapse. To this end, par-
ticipants received evidence-based information about the
psychological process of relapse, emphasizing the rele-
vance of recognizing warning signs of depression. A ses-
sion was dedicated to explaining how healthy habits
(i.e., sleeping, diet, and physical exercise) could improve
low mood. Finally, skills for managing interpersonal and
family conflicts were taught. The intervention had a class
format but unlike ER +M, no homework was assigned. A
psychologist with training in cognitive-behavioral therapy
conducted the control intervention.
See Table 1 for a detailed description of the treatment
curricula.
Measures
Primary outcome measure
The primary outcome measure was time to relapse/recur-
rence of major depression, defined as the emergence of a
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new acute episode according to DSM-IV-TR criteria [21].
The SCID-I was used to assess major depressive criteria.
Secondary outcome measures
To assess changes in depressive symptoms during the
intervention phase, the Beck Depression Inventory
(BDI-II) [22] and the HDRS [23] were used (self-re-
ported and clinician-reported symptoms, respectively).
To assess the impact of both interventions on general psy-
chiatric symptoms, the Symptom Checklist 90 (SCL-90)
[24] was used. The SCL-90 is a self-reported scale con-
taining 90 items rated on a 5-point Likert scale (0 = not at
all, 4 = extremely). The Global Severity Index (GSI) was
used as a global measure of psychopathology. Since one of
the interventions included mindfulness training, the
Mindful Attention Awareness Scale (MAAS) [25] was also
used to assess changes in dispositional mindfulness. The
MAAS is a unifactorial scale that measures the general
tendency to be attentive and aware of the present experi-
ence in daily life. Items are rated on a 6-point Likert type
scale. Respondents rate how often they are acting on auto-
matic pilot, preoccupied, and not paying attention to the
present moment. The MAAS has good internal
consistency and adequate convergent, discriminant and
incremental validity [25].
Statistical analysis
Normality tests (skewness, kurtosis and boxplots) were
performed to determine if the data had a normal distri-
bution. Outliers were not identified. Skewness and kur-
tosis values were within the acceptable range of −2.00 to
+2.00 and −5.00 and +5.00 respectively [26]: skewness
and kurtosis, respectively, ranged from − .17 to .61 and
− .57 to .65. A normal distribution was not confirmed
for the number of previous episodes (Skewness = 5.54
and Kurtosis = 33.93) and thus, a non-parametric test
(Mann-Whitney U Test) was run. Descriptive statistics
and baseline clinical characteristics were analyzed using
either chi-squared test or Fisher’s exact test for categor-
ical variables and t-test for continuous ones.
For the time-to-event data (i.e., time to onset of relapse,
in weeks), Kaplan-Meier curves were plotted. The treat-
ment condition and the control intervention were
compared using long-rank statistics (Mantel-Cox test).
Analyses of secondary outcomes (i.e., BDI-II, HDRS, SCL-
90-GSI and MAAS) were performed in the per-protocol
(PP) population (defined as participants who complete
pre-post assessments) and the intended-to-treat (TT)
sample. For the completers analyses, participants were in-
cluded if they attended ≥ 80% of the interventions. For the
ITT analyses, we used a standard conservative method in
which the participant’s last observation was carried
forward (LOCF) to account for missing data [27]. In
both analyses (i.e., PP and ITT), analyses of covari-
ance (ANCOVA) were performed to compare post-
measurement scores on secondary outcome measures
(i.e., BDI-II, HDRS, SCL-90-GSI and MAAS) between
the two groups (ER +M vs. PE), controlling for base-
line levels. All hypotheses were two-sided and tested
at a significance level of p < .05. Estimated effect sizes
were calculated as Cohen’s d and evaluated as follows:
small = 0.20, moderate = 0.50 and large = 0.80 [28]. All
analyses were performed with the SPSS 19.0 statistical
software package (SPSS-IBM; Chicago, IL, USA).
Table 1 Treatment curricula for both interventions
Condition Week Skills Target problems with
Emotion Regulation +Mindfulness 1 Wise mind, how and what skills Rumination, Depression-related cognitions,
emotions and physical sensations
2
3
4 Understand emotional process:
identify and label emotions
Emotional processing
5
6
7 Opposite Action Changing emotional expressions/behaviors
8
9 Accumulate Positives Reduce vulnerability to depression, increase
positive reinforcement, increase self-efficacy
10 Build Mastery
Psychoeducation 1 Psychological process of relapse Increase patients’ knowledge about depression,
and the mechanisms involved in depressive
relapse2 Recognizing warning signs of
depression
3 How habits affect depression
(e.g. sleep, food, physical activity)
4
5 Managing interpersonal conflict
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Results
Patient flow and dropout
Of the 110 participants assessed for eligibility, a total of
75 were randomized to ER +M (37 patients) or psychoe-
ducation (38). Reasons for exclusion included: failing to
meet inclusion criteria (n = 21) and refusing to partici-
pate in the study (n = 14). The proportion of participants
in total (HDRS <8) or partial (HDRS between 8 and 17)
remission was similar in both groups [X2 (1, N = 78)
= .65, p = .42]. See Table 2.
During the intervention phase, three participants (8%)
dropped out of the treatment group while 10 partici-
pants (26%) dropped out of the control group (Fisher’s
Exact Test: p = .60). Two participants in the ER +M
group missed two or more consecutive sessions (without
providing any justification for doing so) and were there-
fore considered to have dropped out of treatment. One
participant in the treatment group had to abandon ther-
apy due to incompatibilities with work schedule. Of the 10
subjects who abandoned the PE group, eight missed more
than two consecutive sessions and two withdrew due to
life events (one participant moved out of the country and
one had scheduling incompatibilities with work).
After accounting for dropouts, 34 and 28 participants,
respectively, remained in the treatment and control groups.
A total of five patients (two in the treatment group and
three in the control group) were lost to follow-up. No sig-
nificant between-group differences were observed in the
number of subjects lost to follow-up (Fisher’s Exact Test:
p = 0.65) (Fig. 1).
Demographic and clinical characteristics of the sample
Most (79%) of the participants were women. Mean age was
52 years. No differences were observed between the treat-
ment and control groups at baseline in terms of demo-
graphic or clinical characteristics, nor were differences
seen in pharmacological treatments. Similarly, there were
no differences between the groups in the mean number of
previous depressive episodes [U (75) = 626.00, Z = −1.28,
p = .20]. Demographic and clinical characteristics are
summarized in Table 2.
Primary outcome: relapse/recurrence to major depression
Figure 2 shows survival (i.e., non-relapse) over the 62-week
study period for the two groups. No significant differences
between the groups were observed in time to relapse/re-
currence (Long Rank Test, X2 = 2.83, p = .09).
Secondary outcomes: intervention effects on depression,
general psychiatric symptoms, and dispositional
mindfulness
ANCOVAs conducted in the per-protocol sample [be-
tween-subjects factor: group (ER +M, PE); covariate: base-
line scores] revealed a significant main effect of group for
HDRS scores F(1, 53) = 4.08, p = .048] and SCL-90-GSI
scores F(1, 35) = 4.55, p = .04]. These results were
Table 2 Summary of demographics and clinical characteristics at baseline by group
ER +M
(n = 37)
PE
(n = 38)
X2/F t/U p
M SD M SD
Gender (% females) 75.7 81.6 .38 .53
Marital Status (% of married) 58.3 73.3 2.98 .40
Years of education 11.75 5.40 11.35 4.88 .33 .38
Age 51.35 10.73 53.82 10.87 −.98 .33
Number of PDE 2.81 2.51 2.18 .51 626.00 .20
Partial remission (%) 40.5 31.6 .65 .42
Total remission (%) 59.5 68.4
Pharmacological treatment (%)
Antidepressants 91.9 97.4 .35
SSRI (%) 62.2 57.9 .14 .71
TCAs (%) 35.1 34.2 .01 .93
Dual-Action Antidepressants 5.4 5.3 1.00
Other Antidepressants 13.5 21.1 .54
Mood Stabilizers 18.9 23.7 .25 .61
Antipsychotics 8.1 13.2 .71
Benzodiazepines 29.7 36.8 2.21 .51
ER + M Emotion Regulation plus Mindfulness, PE Psychoeducation, PDE Previous Depressive Episodes, SSRI Selective serotonin re-uptake inhibitors, TCAs
Tricyclic antidepressants
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maintained in the ITT analyses, HDRS [F(1,72) = 4.45,
p = .04], and SCL-90-GSI [F(1,72) = 4.24, p = .04]. No
statistically significant differences between conditions were
observed for BDI [F(1,59) = .85, p = .36] or MASS scores
[F(1,39) = 1.05, p = .31] at post-intervention in the PP
sample. The ANCOVAs performed in the ITT sample also
revealed no main effect of group for BDI [F(1,72) = .83, p
= .36 or MASS [F(1,72) = .75, p = .40] scores. Table 3 shows
details of the analyses conducted in the PP sample.
Discussion
The present randomized controlled study sought to in-
vestigate the efficacy of an intervention combining two
DBT skill modules (emotion regulation and mindfulness)
as a prophylactic treatment to prevent MDD relapse.
Our findings indicate that ER +M was not superior to
psychoeducation in terms of the primary outcome meas-
ure: time to depressive relapse. However, ER +M was
more efficacious than the control intervention in redu-
cing depressive and general psychiatric symptoms during
the treatment phase and subjects allocated to this inter-
vention had a better adherence to treatment, as reflected
in lower dropout rates.
Several factors could account for the lack of significant
differences between the interventions in preventing
MDD relapse. Previous evidence has highlighted the im-
portance of severity-related variables when analyzing
treatment outcomes. Prior studies indicate that the num-
ber of previous depressive episodes is a moderating vari-
able for the efficacy of some treatments, such as MBCT
[29, 30]. In addition, the severity of childhood trauma
may also help explain the efficacy of mindfulness-based
interventions over TAU and psychoeducation [30]. In
the present study, we only included patients with at least
two previous depressive episodes. Given that some stud-
ies suggest the patients most likely to benefit from
mindfulness interventions are those with at least three
prior-depressive episodes [31], our cut-off point of two
episodes may not have been sufficiently strict. Another
possible explanation for the lack of significant differ-
ences between the ER +M and psychoeducation groups
on the primary outcome variable could be the non-
specific characteristics (e.g., psychoeducative information
and group support) of the interventions. In the psychoe-
ducation group participants received general information
Self-withdrawal (n = 10)
Screened for eligibility (n = 110)
Randomized (n = 75)
Excluded (n = 35)
14 Declined participation
21 Not meeting inclusion criteria
- HDRS >17 (n = 14)
- Substance abuse (n = 5)
- Bipolar disorder (n = 2)
ER + M (n = 37) Psychoeducation (n = 38)
Self-withdrawal (n = 3)
34 to follow up
- 8 Relapse
- 2 Lost to follow up
28 to follow up
- 11 Relapse
- 3 Lost to follow up
Analysed (n = 32) Analysed (n = 25)
Fig. 1 Diagram showing participant’s flow through the study. ER + M = Emotion Regulation plus Mindfulness skills
Fig. 2 Survival curves comparing relapse to major depression for
emotion regulation plus mindfulness skills (ER + M; n = 37) and
Psychoeducation (PE; n = 38)
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about depression, depression relapse, warning signs of
depression, healthy habits, and interpersonal skills. How-
ever, as suggested in some studies, such as that con-
ducted by Williams [30], these contents could also be
effective in preventing depressive relapse.
The adaptations of the standards DBT skills training that
we implemented in this study could have also influenced
our results. We presented mindfulness skills (two sessions)
at the beginning of the intervention and these skills were
practiced at the beginning of every session thereafter for
10 weeks; we hypothesize that the amount of mindfulness
training may have been insufficient to achieve better
results. Importantly, our study was focused on emotion
regulation and mindfulness skills, leaving aside interper-
sonal and distress tolerance skills, both of which could also
be effective in this population.
The proportion of participants who dropped out during
the intervention phase without providing any explanation
was slightly higher in the PE group (eight patients vs. only
two in the ER +M group). The difference in dropout rates
could be due to differences in the dosage: the ER +M con-
sisted of 10 weekly sessions while PE comprised only five
sessions distributed over the 10-week period. These data
suggest that some of the characteristics of the PE condi-
tion might have been less attractive for participants. It is
possible that the bi-weekly character of the PE interven-
tion negatively affected the participants’ motivation to
attend the sessions. Differences in treatment dosage are a
limitation of our study design.
According to the inclusion criteria, none of the partici-
pants was experiencing an acute depressive phase during
the treatment phase. For this reason, only a discrete re-
duction in depressive symptoms was expected, and this
factor may have influenced treatment outcomes. Never-
theless, it should be noted that most participants were in
partial remission (HDRS scores between 8 and 17). In
the PP sample, we found a moderate effect size in favor
of the ER +M group for improvements in depressive
symptoms (HDRS) and in general psychiatric symptoms.
This result was maintained in the ITT analysis.
Previous studies have shown that interventions that in-
clude mindfulness have a positive impact on well-being
[25] and are efficacious in reducing psychiatric symp-
toms as well as depressive symptomatology [32]. It
would have been interesting to register the participants’
general psychiatric symptoms using the SCL-90 during
the follow-up period in order to explore the temporal
stability of this finding. No differences between groups
were found in MAAS scores. As reported in other studies,
the attentional component of mindfulness (assessed in
the MAAS) seems to be less sensitive to therapeutic
changes than other mindfulness facets [33, 34]. Future
studies should consider using other self-reported
scales that more adequately reflect changes in disposi-
tional mindfulness.
The present study has several limitations. Although
the sample size was considered adequate, the dropout
rates limited the power of the study. Additionally, the
history of childhood trauma (not evaluated in this study)
or the number of previous episodes might also have in-
terfered with the results. Moderators of severity should
be included in future studies to determine if the lack of
differences reported here art attributable or not to the
characteristics of the sample. Differences in the thera-
peutic dosage between interventions could also have
affected our results.
Conclusions
Future research should be conducted to continue exploring
the efficacy of specific DBT skills such as emotion regula-
tion and/or mindfulness to prevent depression relapses. In
this line of research, dismantling studies of DBT skills are
mandatory to better determine which combination of skills
are most efficacious in preventing MDD relapse.
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